lysophosphatidic acid has been researched along with Pancreatic Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, Y; Liu, L; Shi, Z; Yang, J | 1 |
| Ikeda, H; Kurisu, R; Okuda, A; Takai, M; Takamoto, M; Tsujiuchi, T | 1 |
| Cutiongco, MFA; Fort, L; Gadegaard, N; Insall, RH; Juin, A; Kalna, G; Koh, YWH; Lilla, S; Machesky, LM; Mackay, G; Martin, KJ; McGhee, E; Neilson, M; Norman, JC; Spence, HJ; Thomason, P | 1 |
| Chen, J; Guo, X; Li, H; Xu, W | 1 |
| Cui, JJ; Feng, X; Huang, Q; Quan, M | 1 |
| Itadani, M; Katase, N; Kobiki, K; Kuribayashi, F; Nakamura, M; Okada, N; Yamaguchi, Y; Yamamura, M; Yamauchi, A | 1 |
| Dhanasekaran, DN; Gardner, JA; Ha, JH; Jayaraman, M | 1 |
| Liao, Y; Mu, G; Yu, H; Zhang, J; Zhang, L; Zhou, W | 1 |
| Fukushima, K; Fukushima, N; Hirane, M; Ishii, S; Tomimatsu, A; Tsujiuchi, T | 1 |
| Chen, L; Hu, Y; Xing, J; Zheng, Y; Zhou, Z | 1 |
| Aasrum, M; Brusevold, IJ; Christoffersen, T; Sandnes, D; Tveteraas, IH; Ødegård, J | 1 |
| Fukushima, K; Fukushima, N; Honoki, K; Onishi, Y; Takahashi, K; Tsujiuchi, T; Yamasaki, E | 1 |
| Arita, Y; Hisano, T; Ito, T; Kawabe, K; Oono, T; Takayanagi, R | 1 |
| Im, DS; Kimura, T; Komachi, M; Kurose, H; Kuwabara, A; Malchinkhuu, E; Mogi, C; Ohta, H; Okajima, F; Sato, K; Takeyoshi, I; Tobo, M; Tomura, H; Yamada, T | 1 |
| Chen, JF; Gong, YL; Li, P; Lv, GM; Wang, ShK; Wang, WD | 1 |
| Im, DS; Ishii, S; Kimura, T; Komachi, M; Mogi, C; Ohta, H; Okajima, F; Sato, K; Takeyoshi, I; Tobo, M; Tomura, H; Yamada, T; Yanagida, K | 1 |
| Fukui, R; Fukushima, N; Kato, K; Kitayoshi, M; Tanabe, E; Tsujiuchi, T; Yoshikawa, K | 1 |
| Fukushima, N; Inoue, S; Kitayoshi, M; Okimoto, S; Shibata, A; Tanabe, E; Tsujiuchi, T; Yoshikawa, K | 1 |
| Beil, M; Dao, M; Lim, CT; Micoulet, A; Mills, JP; Seufferlein, T; Spatz, J; Suresh, S | 1 |
3 review(s) available for lysophosphatidic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer.
Topics: Cell Movement; Drug Resistance, Neoplasm; Humans; Lysophospholipids; Neoplasm Invasiveness; Neoplastic Stem Cells; Pancreatic Neoplasms; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction; Tumor Microenvironment | 2017 |
Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer.
Topics: Animals; Humans; Lysophospholipids; Pancreatic Neoplasms; Receptors, Lysosphingolipid | 2011 |
Connections between single-cell biomechanics and human disease states: gastrointestinal cancer and malaria.
Topics: Animals; Biomechanical Phenomena; Cell Line, Tumor; Elasticity; Erythrocyte Deformability; Erythrocytes; Gastrointestinal Neoplasms; Humans; In Vitro Techniques; Lysophospholipids; Malaria; Pancreatic Neoplasms; Phosphorylcholine; Plasmodium falciparum; Sphingosine | 2005 |
16 other study(ies) available for lysophosphatidic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
ATX/LPA axis regulates FAK activation, cell proliferation, apoptosis, and motility in human pancreatic cancer cells.
Topics: Animals; Apoptosis; Cell Proliferation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Pancreatic Neoplasms; Signal Transduction | 2022 |
Roles of lysophosphatidic acid (LPA) receptor-2 (LPA
Topics: Cell Movement; Cisplatin; Humans; Hydrogen Peroxide; Pancreatic Neoplasms; Reactive Oxygen Species; X-Rays | 2023 |
N-WASP Control of LPAR1 Trafficking Establishes Response to Self-Generated LPA Gradients to Promote Pancreatic Cancer Cell Metastasis.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Chemotaxis; Female; Humans; Lysophospholipids; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Transport; Rats; Receptors, Lysophosphatidic Acid; rhoA GTP-Binding Protein; Signal Transduction; Sorting Nexins; Wiskott-Aldrich Syndrome Protein, Neuronal | 2019 |
Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer.
Topics: Biomarkers; Humans; Lipoprotein(a); Lysophospholipids; Pancreatic Neoplasms; Phosphoric Diester Hydrolases; Prognosis | 2021 |
Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
Topics: Cell Movement; Humans; In Vitro Techniques; Lysophospholipids; Optical Devices; Pancreatic Neoplasms; Receptors, Lysophosphatidic Acid; Signal Transduction; Tumor Cells, Cultured | 2017 |
The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.
Topics: Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunits, G12-G13; Humans; Immunoblotting; Lysophospholipids; Pancreatic Neoplasms; Protein Binding; Proto-Oncogene Mas; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2013 |
Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Pancreatic Neoplasms; Paxillin; Receptors, Lysophosphatidic Acid; RNA, Messenger | 2013 |
Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Topics: Cell Line, Tumor; Cell Movement; Humans; Lysophospholipids; Neoplasm Invasiveness; Pancreatic Neoplasms; Receptors, Lysophosphatidic Acid; Receptors, Purinergic; Receptors, Purinergic P2 | 2015 |
RGS22 inhibits pancreatic adenocarcinoma cell migration through the G12/13 α subunit/F-actin pathway.
Topics: Actins; Antigens, Surface; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Shape; GTP-Binding Protein alpha Subunits, G12-G13; GTP-Binding Protein Regulators; Humans; Lysophospholipids; Pancreatic Neoplasms; Tumor Suppressor Proteins | 2015 |
Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.
Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; DNA; ErbB Receptors; Gefitinib; HCT116 Cells; HT29 Cells; Humans; Lysophospholipids; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Transcriptional Activation | 2016 |
Lysophosphatidic acid signaling via LPA
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Cisplatin; Disease Progression; Drug Therapy, Combination; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2017 |
Lysophosphatidic acid induced nuclear translocation of nuclear factor-kappaB in Panc-1 cells by mobilizing cytosolic free calcium.
Topics: Adenocarcinoma; Calcium; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Dose-Response Relationship, Drug; Humans; Lysophospholipids; NF-kappa B; Pancreatic Neoplasms; Protein Kinase C; Receptors, Lysophosphatidic Acid; RNA, Messenger; Type C Phospholipases | 2008 |
LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Topics: Ascites; Cell Line, Tumor; Cell Movement; Collagen; Drug Combinations; Epidermal Growth Factor; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Isoxazoles; Laminin; Lysophospholipids; Neoplasm Invasiveness; Pancreatic Neoplasms; Pertussis Toxin; Propionates; Proteoglycans; Receptors, Lysophosphatidic Acid; rhoA GTP-Binding Protein; RNA, Small Interfering | 2009 |
Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Topics: Animals; Ascites; Cell Line, Tumor; Cell Movement; Humans; Isoxazoles; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Peritoneal Neoplasms; Propionates; Receptors, Lysophosphatidic Acid; Xenograft Model Antitumor Assays | 2012 |
Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cricetinae; Gene Knockdown Techniques; Lysophospholipids; Neoplasm Invasiveness; Pancreatic Neoplasms; Receptors, Lysophosphatidic Acid | 2012 |
Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cricetinae; Diphosphates; Gene Knockdown Techniques; Genes, ras; Glycerol; Lysophospholipids; Neoplasm Invasiveness; Pancreatic Neoplasms; Receptors, Lysophosphatidic Acid; Up-Regulation | 2013 |